ArticleTherapeutic advances in gastroenterology2024

High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease.

Jaime González-Antuña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.